Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Aug 24;75(1):e1011-e1019.
doi: 10.1093/cid/ciac054.

Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort

Affiliations
Multicenter Study

Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort

Carol Strahm et al. Clin Infect Dis. .

Abstract

Background: The burden of long-term symptoms (ie, long COVID) in patients after mild COVID-19 is debated. Within a cohort of healthcare workers (HCWs), frequency and risk factors for symptoms compatible with long COVID are assessed.

Methods: Participants answered baseline (August/September 2020) and weekly questionnaires on SARS-CoV-2 nasopharyngeal swab (NPS) results and acute disease symptoms. In January 2021, SARS-CoV-2 serology was performed; in March, symptoms compatible with long COVID (including psychometric scores) were asked and compared between HCWs with positive NPS, seropositive HCWs without positive NPS (presumable asymptomatic/pauci-symptomatic infections), and negative controls. The effect of time since diagnosis and quantitative anti-spike protein antibodies (anti-S) was evaluated. Poisson regression was used to identify risk factors for symptom occurrence.

Results: Of 3334 HCWs (median, 41 years; 80% female), 556 (17%) had a positive NPS and 228 (7%) were only seropositive. HCWs with positive NPS more frequently reported ≥1 symptom compared with controls (73% vs 52%, P < .001); seropositive HCWs without positive NPS did not score higher than controls (58% vs 52%, P = .13), although impaired taste/olfaction (16% vs 6%, P < .001) and hair loss (17% vs 10%, P = .004) were more common. Exhaustion/burnout was reported by 24% of negative controls. Many symptoms remained elevated in those diagnosed >6 months ago; anti-S titers correlated with high symptom scores. Acute viral symptoms in weekly questionnaires best predicted long-COVID symptoms. Physical activity at baseline was negatively associated with neurocognitive impairment and fatigue scores.

Conclusions: Seropositive HCWs without positive NPS are only mildly affected by long COVID. Exhaustion/burnout is common, even in noninfected HCWs. Physical activity might be protective against neurocognitive impairment/fatigue symptoms after COVID-19.

Keywords: asymptomatic; healthcare workers; long COVID; risk factors; serology.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study flow showing the total population and the subpopulations analyzed for specific analyses. Abbreviations: anti-S, anti-spike protein antibodies; COVID, coronavirus disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 2.
Figure 2.
Percentage of HCWs reporting symptom and total number of reported symptoms (upper right corner) by HCWs with a positive SARS-CoV-2 swab (red), seropositive HCWs without a positive swab (orange), and seronegative HCWs without a positive swab (light blue). Statistics: Positive HCWs are compared with negative HCWs, respectively (***P < .001; **P = .001–.01; *P = .01–.05). Abbreviations: HCW, healthcare worker; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 3.
Figure 3.
Sum score for the post-concussion (RMEAD), fatigue severity (FSS), depression (PHQ), and anxiety (GAD) scores by HCWs with a positive SARS-CoV-2 swab (red), seropositive HCWs without a positive swab (orange), and seronegative HCWs without a positive swab (light blue). Statistics: Positive HCWs are compared with negative HCWs, respectively (***P < .001; *P = .01–.05). Abbreviations: FSS, Fatigue Severity Scale; GAD, General Anxiety Disorder; HCW, healthcare worker; PHQ, Patient Health Questionnaire; RMEAD, Rivermead Post-Concussion Questionnaire; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; serol., serology.
Figure 4.
Figure 4.
Percentage of healthcare workers reporting individual symptoms and total number of reported symptoms (upper right corner) according to weeks since positive SARS-CoV-2 swab, compared with negative controls. Statistics: P values from tests for trends over the 4 categories, without negative controls. Abbreviation: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 5.
Figure 5.
Sum score for symptoms, the post-concussion (RMEAD), fatigue severity (FSS), depression (PHQ), and anxiety (GAD) scores according to quartile of SARS-CoV-2 anti-spike titers. Results are adjusted for time since positive swab. Statistics: P values from tests for linear trends over the 4 categories. Abbreviations: FSS, Fatigue Severity Scale; GAD, General Anxiety Disorder; PHQ, Patient Health Questionnaire; Q, quartile; RMEAD, Rivermead Post-Concussion Questionnaire; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 6.
Figure 6.
Forest plot showing the multiplicative effect of potential influential factors on the number of long-COVID symptoms, as determined through multivariable Poisson regression. Factors in blue are negatively and those in red are positively associated with the number of symptoms. Abbreviation: BMI, body mass index; CI, confidence interval; COVID, coronavirus disease; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

References

    1. Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021; 27:601–15. - PMC - PubMed
    1. Silva Andrade B, Siqueira S, de Assis Soares WR, et al. . Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses 2021; 13:700. - PMC - PubMed
    1. Proal AD, VanElzakker MB.. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021; 12:698169. - PMC - PubMed
    1. Ayoubkhani D. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/.... Accessed 22 July 2021.
    1. Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med 2021; 92:55–70. - PMC - PubMed

Publication types